Publication | Open Access
Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer
23
Citations
38
References
2023
Year
BCL2 inhibition overcomes intrinsic resistance and enhances sensitivity to AURKB inhibition in SCLC preclinical models.
| Year | Citations | |
|---|---|---|
Page 1
Page 1